BMS-741672
CAS No. 1004757-96-3
BMS-741672( BMS741672 )
Catalog No. M10035 CAS No. 1004757-96-3
BMS-741672 is a potent, selective CCR2 antagonist for the treatment of neuropathic pain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1863 | Get Quote |
|
| 50MG | 3762 | Get Quote |
|
| 100MG | 5220 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBMS-741672
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS-741672 is a potent, selective CCR2 antagonist for the treatment of neuropathic pain.
-
DescriptionBMS-741672 is a potent, selective CCR2 antagonist for the treatment of neuropathic pain.Diabetes Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsBMS741672
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number1004757-96-3
-
Formula Weight506.574
-
Molecular FormulaC25H33F3N6O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(N[C@H]1[C@@H](N2C([C@@H](NC3=C4C=C(C(F)(F)F)C=CC4=NC=N3)CC2)=O)CC[C@@H](N(C(C)C)C)C1)=O
-
Chemical NameN-((lR,2S,5R)-5-(isopropyl(methyl)amino)-2-((S)-2-oxo-3-(6- (trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-l-yl)cyclohexyl)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Joerg Deerberg, et al. Org. Process Res. Dev., 2016, 20 (11), pp 1949-1966.
molnova catalog
related products
-
Plerixafor octahydro...
Plerixafor?octahydrochloride (JM-3100, AMD-3100, SID-791) is a potent, selective CXCR4 inhibitor (IC50=44 nM) that inhibits the replication of various HIV-1 and HIV-2 strains in various cell lines with EC50 of 10ng/ml.
-
ST 016907
A potent CCR4 antagonist that blocked CCL22- and CCL17-mediated migration of human peripheral blood CD4+CD25+ Treg and Th2 cells ex-vivo and murine Tregs in-vivo.
-
CCX140
A potent, selective, orally bioavailable CCR2 antagonist with Kd of 2.3 nM for hCCR2.
Cart
sales@molnova.com